Document:

Exhibit 10.15 

May 7, 2007

Mr. Richard
Grossi

Johns Hopkins Medicine

733 N. Broadway

Suite 100

Baltimore, MD 21205

	
 

	
 

	
 

	
 

	
Re:

	
Consulting
  and Services Agreement between Advanced Aesthetics, Inc. and Johns Hopkins
  Medicine dated November 23, 2003 and as amended by the First Amendment dated
  March 23, 2005 (collectively the “Consulting Agreement”);

	
 

	
 

	
 

	
License and
  Management Agreement between Johns Hopkins University and Klinger Advanced
  Aesthetics, LLC for the Chevy Chase facility (the “License and Management
  Agreement”);

Dear Mr.
Grossi:

          This
letter shall serve as modification to both the Consulting Agreement and the
License and Management Agreement. 

The
Consulting Agreement

          Effective
April 13, 2007, the Consulting Agreement is terminated. KAA (“KAA” shall refer
to Klinger Advanced Aesthetics, Inc. or any affiliated entity) shall pay Johns
Hopkins (“Johns Hopkins” shall refer to Johns Hopkins Medicine, Johns Hopkins
University, Johns Hopkins Health System and to any affiliated entities of same)
$369,565 (the “Payment”) by July 31, 2007. Upon receipt of the Payment no
further amount shall be owed or owing to Johns Hopkins under the Consulting
Agreement. Effective April 13, 2007, Johns Hopkins shall no longer provide to
KAA any further services under the Consulting Agreement, and, KAA shall no
longer use the Johns Hopkins name in KAA’s medical facilities.

The
License and Management Agreement

          Effective
May 13, the License and Management Agreement shall be terminated. By May 21,
KAA shall pay to Johns Hopkins all amounts owing under the License and
Management Agreement, and upon receipt of such payment no further amounts shall
be owed or owing to Johns Hopkins under the License and Management Agreement. 

501 Merritt 7, 5th Floor, Norwalk,
CT 06851 (P) 203-295-2121 (F) 203-295-2102

www.aai.com

This letter
merely sets forth the financial agreements between the parties and it is
understood that further detailed legal agreements will be executed between the
parties. If the above meets with your understanding please return a
countersigned agreement to my attention.

	
 

	
 

	
 

	
 

	
Sincerely,

	
 

	
 

	
 

	
Wade Haddad

	
 

	
SVP and
  General Counsel

	
 

	
Klinger
  Advanced Aesthetics, Inc. 

	
 

	
 

	
Read and Approved

	
 

	
 

	
 

	
Johns
  Hopkins Medicine

	
 

	
 

	
 

	
 

	
By:

	
 

	
 

	
 

	

	
 

	
 

	
 

	
 

	
Johns
  Hopkins University

	
 

	
 

	
 

	
By:

	
 

	
 

	
 

	

	
 

	
 

	
 

	
Johns
  Hopkins Health System Corporation

	
 

	
 

	
 

	
By:

	
 

	
 

	
 

	

	
 

501 Merritt 7, 5th Floor, Norwalk,
CT 06851 (P) 203-295-2121 (F) 203-295-2102

www.aai.comc48412_ex10-16.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

Exhibit 10.16

501 Merritt 7 5th Floor

Norwalk, CT 06851 

 

May 4, 2007

Mr. Richard R. Rakowski

145 Springhouse Road 

Fairfield, CG 06905 

Dear Richie:

The purpose of this letter is to confirm our agreement that you will be paid from May 1, 2007 to August 31, 2007 at a rate equivalent to an annual $295,000 consulting fee. From September 1, 2007 to December 31, 2007,
the equivalent annual fee will decrease to $175,000. From January 1, 2008, the equivalent annual fee will decrease to $125,000. Payments will be made within fifteen business days following the close of each month worked or termination of
this agreement. 

This agreement does not include access to any company benefit programs. Either party may terminate this agreement at anytime without liability, including severance, or obligation other than salary earned but not paid at the
date of termination. 

We have agreed you will help the company,

	Maintain, strengthen, and expand its relationship with Sephora. This activity will be measured by Cosmedicine sales to Sephora, Sephora’s continued economic and executive team support for Cosmedicine, and the overall
quality of the Company’s dealings with Sephora. 
	
Facilitate the rapid building of an equally strong and productive relationship between Sephora and the Company’s CEO Pat O’Crowley. This will be measured by how quickly the relationship is established and the
quality of the relationship. 
	
Help develop and expand the Company’s and CEO Pat O’Crowley’s relationship with LVMH. This will be measured by the amount of “growth equity” LVMH invest in the company and the terms of that
investment—target is as simple equity investment without other provisions—and the overall quality of the Company’s and O’Crowley’s relationships with LVMH management. 
	
Assist the Company by developing and maintaining high Company visibility in the medical community including ASPS, select educational institutions, practice groups, and other professional organizations as determined by the
Company. 
	
Carrying out special projects requested by the CEO.
These projects may include but are not limited to creating targeted strategic
relationships for professional line distribution and further raising of the company’s
image and profile in the clinical skincare community. 

The Company will reimburse you for reasonable cash travel expenses that reflect both the nature of your work and the Company’s modest and severely limited cash resources. 

	
Mr. Richard Rakowski
		 
		
 May 4, 2007
    

	
Consulting Agreement
		 
		
      Page 2 of 2
      

Recognizing you can create shareholder value by helping bring both J&J and LVMH “to the table,” the Company will pay a 2.5% success fee based on the actual cash provided to the Company on the closing of a sale
of K360 to J&J or a straight LVMH equity investment into to the Company. You agree to reduce any success fee earned by the amount of professional fees paid, but not previously “offset” against earned success fees. 

The opportunity to earn a success fee applies only to J&J’s purchases of the K360 technology and LVMH’s direct “growth capital” investment into the company. Both transactions must close and fund
within six months from date of this agreement. 

You agree to work closely with and under the guidance of the Company’s CEO on both transactions. You further agree that any deal worked between J&J and /or LVMH must be acceptable to the company’s CEO, its
board of directors, and to Laurus. 

By signing below you acknowledge and accept the above and conditions. 

Sincerely yours, 

/s/ James F. O’Crowley                              

James F. O’Crowley 

  President and Chief Executive Officer

 

	Acknowledged and Accepted:	/s/ Richard Rakowski	 	5/8/07	 
	 	Richard Rakowski	 	Datec48412_ex10-17.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

Exhibit 10.17

TrueYou.Com Inc. 

501 Merritt 7, 5th Floor 

Norwalk, Connecticut 06851 

March 12, 2007 

Dear: 

     As you know, TrueYou.Com Inc. (the “Company”) is in need of additional capital in order to remain in business and continue its operations. As you also know, Laurus Master Fund Ltd.
(“Laurus”) has previously loaned the Company $25,000,000 in Senior Debt and $1,000,000 in Senior Subordinated Debt. On March 8, 2007, Laurus accelerated the maturity of the Senior Debt by written notice to the Company which Senior
Debt is now approximately $28,375,000.

     The Company has received a proposal from Laurus whereby Laurus (and others described below) would loan the Company an aggregate of $53,375,000 of which approximately $28,375,000 would be used
to repay the outstanding Senior Debt and $25,000,000 would constitute new Senior Debt. The new loan of approximately $25,000,000 includes $21,000,000 from Laurus and a total of $4,000,000 from North Sound Capital LLC, Seapine
Investments LLC, existing shareholders of the Company and Andrew Lipman, a director and shareholder of the Company (North Sound, Seapine and Lipman together with Laurus, the “Laurus Investor Group”) who have agreed to loan $3,000,000,
$750,000 and $250,000, respectively.  A term sheet for the proposed Laurus investment which contemplates the additional $4 Million co-investment as a part thereof is attached hereto. 

It is anticipated that as a result of the transaction: 

	
the Laurus Investor Group will receive warrants with a nominal exercise price to acquire 75% of the equity of the Company (subject to reduction upon specified events as set forth in the term sheet);
	
holders of the senior subordinated debt and the subordinated debt will in exchange for their debt, own in the aggregate approximately 10% of the equity of the Company;
	
holders of Series C Preferred Stock and Series D preferred Stock will in exchange for their preferred shares, own in the aggregate approximately 4% of the equity of the Company;
and
	
all other securityholders, including the holders of Series B Preferred Stock, common stock, outstanding warrants and outstanding options will own approximately 1% of the equity
of the Company.

     Accordingly and in order to
implement this necessary financing, this will confirm your agreement that at
such time after the date hereof (but not later than May 15, 2007), the Company 

raises a minimum of $20,000,000 in gross proceeds (whether
by loan from the Laurus Investor Group or otherwise), then at the closing of such transaction, your loan to the Company in the amount of $150,000, made pursuant to the Loan Agreement among the Company, the undersigned and others, dated December 22, 2006,
shall automatically be converted into 59.14222193 shares of a newly created Series E Convertible Preferred Stock of the Company. A copy of the Certificate of Designation for the Series E Preferred Stock which will rank pari passu with the Series B Preferred Stock is attached hereto. 

     You understand that all of the foregoing is material non-public information and agree to hold such information in confidence in compliance with applicable securities laws.

     If you have any questions, please contact Dan Richardson at DRichardson@kiddcompany.com. 

	 

		 
		
Very truly yours,
	
	 

		 
		
TrueYou.Com Inc.
	
	 

	
	 

		 
		
By:
_______________________
	
	 

		 
		
       Matthew Burris
	
	 

		 
		
       Chief Financial Officer
	
	 

	
	 

	
	
Agreed:
		 
		 

	

2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}]]